Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/21 02:13:21 pm
141.125 EUR   -1.10%
10:09aMERCK KGAA : Bernstein remains Neutral
MD
07:11aMERCK KGAA : JP Morgan maintains a Buy rating
MD
06:49aMERCK KGAA : UBS reaffirms its Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : JP Morgan remains Neutral

11/16/2020 | 07:59am EST

In his latest research note, analyst Richard Vosser confirms his recommendation. The broker JP Morgan is keeping its Neutral rating. The target price remains set at EUR 130.


© MarketScreener with dpa-AFX Analyser 2020
All news about MERCK KGAA
10:09aMERCK KGAA : Bernstein remains Neutral
MD
07:11aMERCK KGAA : JP Morgan maintains a Buy rating
MD
06:49aMERCK KGAA : UBS reaffirms its Neutral rating
MD
05:23aMERCK : Discontinues Phase III Clinical Trial For Lung Cancer Drug On Failure To..
MT
01/20MERCK KGAA : Credit Suisse gives a Buy rating
MD
01/20MERCK KGAA : Sell rating from Goldman Sachs
MD
01/20MERCK : Shares Fall After Announcement of Cancer-Drug Trial Interruption
DJ
01/20MERCK KGAA : Receives a Buy rating from JP Morgan
MD
01/20Merck KGaA, GSK suffer lung cancer drug setback
RE
01/20MERCK : stops lung cancer trial testing drug hopeful bintrafusp alfa
RE
More news
Financials
Sales 2020 17 362 M 21 100 M 21 100 M
Net income 2020 1 977 M 2 402 M 2 402 M
Net Debt 2020 11 147 M 13 547 M 13 547 M
P/E ratio 2020 31,3x
Yield 2020 0,98%
Capitalization 62 043 M 75 058 M 75 401 M
EV / Sales 2020 4,22x
EV / Sales 2021 3,92x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 138,19 €
Last Close Price 142,70 €
Spread / Highest target 18,4%
Spread / Average Target -3,16%
Spread / Lowest Target -29,2%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA1.67%75 058
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD11.39%27 359
KYOWA KIRIN CO., LTD.0.43%14 729
BETTA PHARMACEUTICALS CO., LTD.28.34%8 355
YUHAN CORPORATION-2.53%4 163
RECIPHARM AB (PUBL)3.74%2 732